Literature DB >> 22584799

Clinical course and outcome for critically ill children with Down syndrome: a retrospective cohort study.

Shane M Tibby1, Andrew Durward, Chong Tien Goh, Kentigern Thorburn, Kevin Morris, Mike Broadhead, Mark J Peters.   

Abstract

PURPOSE: Children with Down syndrome (DS) have several genetic anomalies within chromosome 21 which may influence their response to critical illness. We compared the intensive care course and outcome of children with DS versus those without.
METHODS: Retrospective cohort study in four English paediatric intensive care units (ICUs) (2003-2009, n = 33,485). We examined, via a competing risks model, whether risk (subhazard) for ICU mortality differed for children with DS, after adjusting for important confounders.
RESULTS: DS patients exhibited lower disease severity at ICU admission but subsequently required a higher proportion of cardiovascular support, and similar renal support to non-DS patients. Children with DS (n = 1,278) had lower crude mortality than those without (4.2 versus 6.2 %, p = 0.003). This was not significant when expressed as standardized mortality ratio: 0.83 [95 % confidence interval (CI) 0.63-1.09] versus 0.90 (95 % CI 0.86-0.94). However, the competing risks model showed that mortality risk was influenced by length of ICU stay. At admission, DS patients exhibited a subhazard for mortality of 0.63 (95 % CI 0.46-0.85), which increased to 1.00 by day 10 of admission, and continued rising above that of non-DS children thereafter.
CONCLUSIONS: Children with DS require a higher proportion of organ support than expected by disease severity at ICU admission. In addition, the mortality risk for children with DS is dependent upon length of ICU stay. These findings could reflect differences in case mix, but are also compatible with different response to critical illness in this group.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22584799     DOI: 10.1007/s00134-012-2589-x

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  26 in total

1.  Survival in critical illness is associated with early activation of mitochondrial biogenesis.

Authors:  Jane E Carré; Jean-Christophe Orban; Lorenza Re; Karen Felsmann; Wiebke Iffert; Michael Bauer; Hagir B Suliman; Claude A Piantadosi; Terry M Mayhew; Patrick Breen; Martin Stotz; Mervyn Singer
Journal:  Am J Respir Crit Care Med       Date:  2010-06-10       Impact factor: 21.405

2.  Multiorgan failure is an adaptive, endocrine-mediated, metabolic response to overwhelming systemic inflammation.

Authors:  Mervyn Singer; Vincenzo De Santis; Domenico Vitale; William Jeffcoate
Journal:  Lancet       Date:  2004 Aug 7-13       Impact factor: 79.321

3.  Impact of DEL22q11, trisomy 21, and other genetic syndromes on surgical outcome of conotruncal heart defects.

Authors:  Guido Michielon; Bruno Marino; Gianluca Oricchio; Maria Cristina Digilio; Fiore Iorio; Sergio Filippelli; Silvia Placidi; Roberto M Di Donato
Journal:  J Thorac Cardiovasc Surg       Date:  2009-05-23       Impact factor: 5.209

4.  The four ages of Down syndrome.

Authors:  Alan H Bittles; Carol Bower; Rafat Hussain; Emma J Glasson
Journal:  Eur J Public Health       Date:  2006-07-19       Impact factor: 3.367

5.  Risk of death for children with down syndrome and sepsis.

Authors:  Michelle M Garrison; Howard Jeffries; Dimitri A Christakis
Journal:  J Pediatr       Date:  2005-12       Impact factor: 4.406

Review 6.  Cognitive deficits and associated neurological complications in individuals with Down's syndrome.

Authors:  Ira T Lott; Mara Dierssen
Journal:  Lancet Neurol       Date:  2010-06       Impact factor: 44.182

7.  At the coalface--medical ethics in practice. Futility and death in paediatric medical intensive care.

Authors:  I M Balfour-Lynn; R C Tasker
Journal:  J Med Ethics       Date:  1996-10       Impact factor: 2.903

8.  Timing and predictors of death in pediatric patients with multiple organ system failure.

Authors:  F Proulx; M Gauthier; D Nadeau; J Lacroix; C A Farrell
Journal:  Crit Care Med       Date:  1994-06       Impact factor: 7.598

9.  Uric acid and allantoin levels in Down syndrome: antioxidant and oxidative stress mechanisms?

Authors:  Ingrid Zitnanová; Peter Korytár; Okezie I Aruoma; Mária Sustrová; Iveta Garaiová; Jana Muchová; Terézia Kalnovicová; Siegfried Pueschel; Zdenka Duracková
Journal:  Clin Chim Acta       Date:  2004-03       Impact factor: 3.786

10.  High incidence of acute lung injury in children with Down syndrome.

Authors:  M Bruijn; L B van der Aa; R R van Rijn; A P Bos; J B M van Woensel
Journal:  Intensive Care Med       Date:  2007-08-03       Impact factor: 17.440

View more
  3 in total

1.  Down syndrome and postoperative complications after paediatric cardiac surgery: a propensity-matched analysis.

Authors:  Roland Tóth; Péter Szántó; Zsolt Prodán; Daniel J Lex; Erzsébet Sápi; András Szatmári; János Gál; Tamás Szántó; Andrea Székely
Journal:  Interact Cardiovasc Thorac Surg       Date:  2013-07-05

Review 2.  Year in review in Intensive Care Medicine 2012: III. Noninvasive ventilation, monitoring and patient-ventilator interactions, acute respiratory distress syndrome, sedation, paediatrics and miscellanea.

Authors:  Massimo Antonelli; Marc Bonten; Maurizio Cecconi; Jean Chastre; Giuseppe Citerio; Giorgio Conti; J R Curtis; Goran Hedenstierna; Michael Joannidis; Duncan Macrae; Salvatore M Maggiore; Jordi Mancebo; Alexandre Mebazaa; Jean-Charles Preiser; Patricia Rocco; Jean-François Timsit; Jan Wernerman; Haibo Zhang
Journal:  Intensive Care Med       Date:  2013-01-22       Impact factor: 17.440

3.  Weight-for-age distribution and case-mix adjusted outcomes of 14,307 paediatric intensive care admissions.

Authors:  Nicholas J Prince; Katherine L Brown; Teumzghi F Mebrahtu; Roger C Parslow; Mark J Peters
Journal:  Intensive Care Med       Date:  2014-07-18       Impact factor: 17.440

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.